Provided the critical roles of MYC and TGF-β signaling in the advanced prostate cancer subtypes, our results highly suggest curcumin as a novel anti-cancer supplementary treatment option for non-indolent prostate cancer resistant to hormone and chemical therapies. The gene discussed is TGFB1; the disease is prostate cancer.